Skip to main content
SpringerLink
Log in

Advances in the Therapy of Non-Hodgkin’s Lymphoma

  • Conference paper
Strategies in Clinical Hematology

  • 74 Accesses

Abstract

During the past decade considerable progress has been made in the therapeutic management of non-Hodgkin’s lymphoma (NHL). Classification, staging, and other factors related to prognosis have been critically revised. New therapeutic strategies have been developed on the basis of successful simultaneous application of antitumor drugs. New agents have been synthetized which proved to be useful as second and third choice treatment compounds. Within the plan of a multimodality approach the value of radiotherapy became reassessed. Immunotherapeutic investigations were initiated. As a result of these numerous efforts the goal: to cure NHL patients has been set closer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rappaport, H.: Classification of neoplastic diseases of the reticular system. In: Symposium on lymphoreticular tumours in Africa, Paris 1963. Roulet, F. C. (ed.), pp. 394–409. Basel, New York: Karger 1964

    Google Scholar 

  2. Eckhardt, S.: Lymphosarcoma and reticulum cell sarcoma: Prognostic factors and criteria of response. In: Cancer therapy. Prognostic factors and criteria of response. Staquet, M. (ed.), pp. 131–137. New York: Raven 1975

    Google Scholar 

  3. Bodey, G. P., Rodríguez, V.: Approaches to the treatment of acute leukemia and lymphoma in adults. In: Leukemia and lymphoma. Freireich, E. J., Hersh, E. M., Miescher, P. A., Jaffé, E. R. (eds.), pp. 159–199. New York, San Francisco, London: Grune & Stratton 1978

    Google Scholar 

  4. Lukes, R. J., Collins, R. D.: A functional approach to the classification of malignant lymphoma. In: Recent results in cancer research, Vol. 46, pp. 18–30. Berlin, Heidelberg, New York: Springer 1974

    Google Scholar 

  5. Mathé, G., Rappaport, H., O’Conor, G. T., Torloni, H.: Histological and cytological typing of neoplastic diseases of haemopoietic and lymphoid tissues. International histological classification of tumors. 14. Geneva: World Health Organization 1976

    Google Scholar 

  6. Lennert, K.: Malignant lymphomas other than Hodgkin’s disease. In: Handbuch der speziellen pathologischen Anatomie und Histologie, Vol. I/3B. Uehlinger, E. (ed.). Berlin, Heidelberg, New York: Springer 1978

    Google Scholar 

  7. Gérard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A. G., Van Unnik, J. A. M.: Classification of non-Hodgkin’s lymphomas. Lancet 1974 II, 406–408

    Google Scholar 

  8. Musshoff, K., Schmidt-Vollmer, H., Lennert, K., Sandritter, W.: Preliminary clinical findings on the Kiel classification of malignant lymphomas. Z. Krebsforsch. 87, 229–238 (1970)

    Article  Google Scholar 

  9. Van Unnik, J. A. M., Breur, K., Burgers, J. M. V., Cleton, F., Hart, A. A. M., Stenfert Kroese, W. F., Somers, R., Van Turnhout, J. P. M. P. M.: Non-Hodgkin’s lymphomata: Clinical features in relation to histology. Br. J. Cancer [Suppl. II] 31, 201–207 (1975)

    Google Scholar 

  10. Brittinger, G., Bartels, H., Bremer, K., Dühmke, F., Gunzer, U., König, E., Stein, H.: Klinik der malignen non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphoblastisches Lymphom, immunobla-stisches Lymphom. Hämatol. Bluttransfus. 18, 211–223 (1976)

    PubMed  CAS  Google Scholar 

  11. Stacher, A., Waldner, R., Theml, H.: Klinik der malignen non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: lymphoplasmozytoides Lymphom (LPL) und chronisch lymphatische Leukämie (CLL). Hämatol. Bluttransfus. 18, 199–209 (1976)

    Google Scholar 

  12. Silvestrini, R., Piazza, R., Riccardi, A., Rilke, F.: Correlation of cell kinetic findings with morphology of non-Hodgkin’s malignant lymphomas. J. Natl. Cancer Inst. 58, 499–504 (1977)

    PubMed  CAS  Google Scholar 

  13. Cabanillas, F., Burke, J. S., Smith, T. L.: Factors predicting for response and survival in adults with advanced non-Hodgkin’s lymphoma. Arch. Intern. Med. 138, 413–418 (1978)

    Article  PubMed  CAS  Google Scholar 

  14. Pinkel, D., Johnson, W., Aur, R. J. A.: Non-Hodgkin’s lymphomata in children. Br. J. Cancer 31, 298–310 (1975)

    Google Scholar 

  15. Rosenberg, H., Diamond, J., Jaslowitz, B., Craver, L.: Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 40, 31–84 (1961)

    Article  CAS  Google Scholar 

  16. Rosenberg, S. A., Boiron, M., De Vita, V. T., Johnson, R. E., Lee, B. J., Ultmann, J. E., Viamante, M.: Report of the committee on Hodgkin’s disease staging procedures. Cancer Res. 31, 1862–1876 (1971)

    PubMed  CAS  Google Scholar 

  17. Reimer, R. R., Chabner, B. A., Young, R. C.: Lymphoma presenting in bone. Results of histopathology, staging and therapy. Ann. Intern. Med. 87, 50–55 (1977)

    PubMed  CAS  Google Scholar 

  18. Lee, B. J., Nelson, J. H., Schwartz, G.: Evaluation of lymphangiography, interior cavography and intravenous pyelography in the clinical staging and management of Hodgkin’s disease and lymphosarcoma. N. Engl. J. Med. 271, 327–337 (1964)

    Article  PubMed  CAS  Google Scholar 

  19. Chabner, B. A., Johnson, R. E., Young, R. C.: Sequential nonsurgical and surgical staging of non-Hodgkin’s lymphoma. Ann. Intern. Med. 85, 149–154 (1976)

    PubMed  CAS  Google Scholar 

  20. Clarysse, A., Kenis, Y., Mathé, G.: Cancer chemotherapy, pp. 360–361. In: Recent Results in Cancer Research, Vol. 53. Berlin, Heidelberg, New York: Springer 1976

    Google Scholar 

  21. Bonadonna, G., Lattuada, A., Banfi, A.: Recent trends in the treatment of non-Hodgkin’s lymphomas. Eur. J. Cancer 12, 661–673 (1976)

    Article  PubMed  CAS  Google Scholar 

  22. Hoogstraten, B., Owens, A. H., Lenhard, R. E.: Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma. Blood 33, 370–378 (1969)

    PubMed  CAS  Google Scholar 

  23. Luce, J. K., Gamble, J. F., Wilson, H. E.: Combined cyclophosphamide, vincristine and prednisone therapy of malignant lymphomas. Cancer 28, 306 (1971)

    Article  PubMed  CAS  Google Scholar 

  24. Bagley, C., De Vita, V. T., Berard, C. W., Candios, D. P.: Intensive cyclical chemotherapy with cyclophosphamide, vincristine and prednisone. Ann. Intern. Med. 76, 227–234 (1972)

    PubMed  Google Scholar 

  25. Skarin, A. T., Pinkus, G. S., Myerowitz, R. L., Bishop, Y. M., Moloney, W. C.: Combination chemotherapy of advanced lymphocytic lymphoma: Importance of histologic classification in evaluating response. Cancer 34, 1023–1029 (1974)

    Article  PubMed  CAS  Google Scholar 

  26. Portlock, C. S., Rosenberg, S. A.: Combination chemotherapy with cyclophosphamide, vincristine and prednisone in advanced non-Hodgkin’s lymphomas. Cancer 37, 1275–1282 (1976)

    Article  PubMed  CAS  Google Scholar 

  27. Stein, R. S., Moran, E. M., Desser, R. K., Miller, J. B., Golomb, H. M., Ultmann, J. E.: Combination chemotherapy of lymphomas other than Hodgkin’s disease. Ann. Intern. Med. 81, 601–609 (1974)

    PubMed  CAS  Google Scholar 

  28. Schein, P. S., Chabner, B. A., Canellos, G. P., Young, R. C., Berard, C., De Vita, V. T.: Potential for prolonged disease free survival following combination chemotherapy of non-Hodgkin’s lymphoma. Blood 43, 181–189 (1974)

    PubMed  CAS  Google Scholar 

  29. Luce J. K., De Laney, F. C., Gehan, E. A.: Remission induction chemotherapy of disseminated malignant lymphoma with combination bleomycin, cyclophosphamide, vincristine and prednisone. Proc. Am. Assoc. Cancer Res. 14, 66 (1973)

    Google Scholar 

  30. Mc Kelvey, E. M., Gottlieb, J. A., Wilson, H. E.: Hydroxydaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38, 1484–1493 (1976)

    Article  CAS  Google Scholar 

  31. Skarin, A. T., Rosenthal, D. S., Moloney, W. C.: Combination chemotherapy of advanced non-Hodgkin’s lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine and prednisone (BACOP). Blood 49, 759–770 (1977)

    PubMed  CAS  Google Scholar 

  32. Schein, P. S., De Vita, V. T., Hubbard, S.: Bleomycin, adriamycin, cyclophosphamide, vincristine and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann. Intern. Med. 82, 351–358 (1976)

    Google Scholar 

  33. Rodriguez, V., Cabanillas, F., Burgess, M. A.: Combination chemotherapy (“CHOP-Bleo”) in advanced (non-Hodgkin) malignant lymphomas. Blood 49, 325–333 (1977)

    PubMed  CAS  Google Scholar 

  34. Misset, J. L., Pouillart, P., Amiel, J. L., Schwarzenberg, L., Hayat, M., De Vassal, F., Musset, M., Belpomme, D., Jasmin, C., Albahary, C., Depierre, R., Mathé, G.: Combinaison d’adriamycine, de VM-26, de cyclophosphamide, et de prédnisone (AVmCP) pour la chimiothérapie des lympho-réticulosarcomes disséminés. Nouv. Presse Méd. 4, 3117–20 (1975)

    PubMed  CAS  Google Scholar 

  35. Ezdinli, E., Pocock, S., Berard, C. W., Aungst, C. W., Silverstein, M., Horton, J., Bennett, J., Bakemeier, R., Stolbach, L., Perlia, C., Brunk, S. F., Lenhard, R. E., Klaassen, D. J., Richter, P., Carbone, P.: Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas. Cancer 38, 1060–1068 (1976)

    Article  PubMed  CAS  Google Scholar 

  36. Durant, J. R., Loeb, V., Dorfman, R., Yick-Kwong, G.: 1,2-bis/2-chloroethyl/-1-Nitrosourea (BCNU) cyclophosphamide, vincristine and prednisone (BCOP). Cancer 36, 1936–1944 (1975)

    Article  PubMed  CAS  Google Scholar 

  37. Sweet, D. L.: Chemotherapy of NHL with unfavorable histologies. In: Symposion on chemotherapy of non-Hodgkin’s lymphoma. Current Chemotherapy Proceedings of the 10th Internat. Congress of Chemotherapy, Zürich. Siegenthaler, W., Lüthy, R. (eds.), Vol. 1, pp. 91–96. Washington, D.C.: Publ. American Society for Microbiology 1978

    Google Scholar 

  38. De Vita, V. T., Canellos, G. P., Chabner, B., Hubbard, S. P., Schein, P., Young, R. C.: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1975 I, 248–250

    Google Scholar 

  39. Levitt, M., Marsh, J. C., De Conti, R. C., Mitchell, M. S., Skeel, R. T., Farber, L. R., Bertino, J. R.: Combination sequential chemotherapy in advanced reticulum cell sarcoma. Cancer 29, 630–636 (1972)

    Article  PubMed  CAS  Google Scholar 

  40. Berd, D., Cornog, J., De Conti, R. C., Levitt, M., Bertino, J. F.: Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy. Cancer 35, 1050–1054 (1975)

    Article  PubMed  CAS  Google Scholar 

  41. Fuller, L. M., Banker, F. L., Butler, J. J., Gamble, J. F., Sullivan, M. P.: The natural history of non-Hodgkin’s lymphoma. Stage I and II. Br. J. Cancer [Suppl. II] 31, 402–413 (1975)

    Google Scholar 

  42. Tubiana, M., Pouillart, P., Hayat, M., Schlienger, M., Gerard-Marchant, R., Schlumberger, J., Brugere, J., Amid, J. L., Mathé, G.: Results of radiotherapy in stage I and II of non-Hodgkin’s lymphoma. Br. J. Cancer [Suppl. II] 31, 270–282 (1975)

    Google Scholar 

  43. Peckham, M. J., Guay, J. P., Hamlin, M. E., Lukes, R. J.: Survival in localized nodal and extranodal non-Hodgkin’s lymphomata. Br. J. Cancer 31, 413–419 (1975)

    Article  Google Scholar 

  44. Patchefsky, A. S., Brodovsky, H. S., Menduke, H., Southard, M., Brooks, J., Nicklas, D., Hoch, W. S.: Non-Hodgkin’s lymphomas: a clinicopathologic study of 293 cases. Cancer 34, 1173–1180 (1974)

    Article  PubMed  CAS  Google Scholar 

  45. Lattuada, A., Banfi, A., Basso Ricci, S., Milani, F., Uslenghi, C., Volterrani, F., Zucali, R.: Non-Hodgkin’s lymphoma results after treatment in stage I and II in 250 cases. In: Proc. XIth Int. Cancer Congr. 1974. Bucalossi, P., Veronesi, U., Cascinelli, M. (eds.), Vol. 4, p. 808. Amsterdam: Excerpta Medica 1975

    Google Scholar 

  46. Van der Werff-Messing, B. U. R.: Reticulum cell sarcoma and lymphosarcoma. A retrospective study of potential survival in loco-regional disease. Eur. J. Cancer 4, 549–553 (1968)

    Article  Google Scholar 

  47. Freeman, G., Berg, J. W., Cutler, S. J.: Occurrence and prognosis of extranodal lymphomas. Cancer 29, 252–266 (1972)

    Article  PubMed  CAS  Google Scholar 

  48. Lattuada, A., Bonadonna, G., Milani, F., Banfi, A., Valagussa, P., De Lena, M., Monfardini, S.: Adjuvant chemotherapy with CVP after radiotherapy (RT) in stage I–II non-Hodgkin’s lymphomas. In: Adjuvant therapy of cancer. Salmon, S. S., Jones, S. E. (eds.), pp. 537–544. Amsterdam: North Holland 1977

    Google Scholar 

  49. Glatstein, E., Portlock, C., Rosenberg, S. A., Kaplan, H. S.: Combined modality treatment in the malignant lymphomas. In: Adjuvant therapy of cancer. Salmon, S. S., Jones, S. E. (eds.), pp. 545–548. Amsterdam: North Holland 1977

    Google Scholar 

  50. Sokal, J. E., Moyaeri, H., Aungst, C. W.: BCG immunotherapy in malignant lymphoma. In: BCG in cancer immunotherapy. Lamourex, G., Turcotte, R., Portelance, C. (eds.), pp. 287–294. New York: Grune & Stratton 1976

    Google Scholar 

  51. Thomas, J. W., Plenderleith, I. H., Landi, S.: BCG as maintenance therapy in non-Hodgkin’s lymphoma. In: BCG in cancer immunotherapy. Lamourex, G., Turcotte, R., Portelance, C. (eds.), pp. 295–302. New York: Grune & Stratton 1976

    Google Scholar 

  52. Rosenberg, S. A., Kaplan, H. S.: Clinical trials in the non-Hodgkin’s lymphomata at Stanford University. Experimental design and preliminary results. Br. J. Cancer 31, 456–464 (1975)

    Google Scholar 

  53. Canellos, G. P., De Vita, V. T., Young, R. C., Chabner, B. A., Schein, P. S., Johnson, R. E.: Therapy of advance lymphocytic lymphoma. A preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Br. J. Cancer [Suppl. II] 31, 324–331 (1975)

    Google Scholar 

  54. Obrecht, J. P.: Die Non-Hodgkin-Lymphome: Klassifikation, „Staging“und Therapie. Schweiz. Med. Wochenschr. 100, 403–409 (1979)

    Google Scholar 

  55. Eckhardt, S., Hindy, I., Farkas, E.: Clinical pharmacological studies with formyl-leurosine in malignant disease. In: Chemotherapy, Vol. 8: Cancer Chemotherapy II. Hellmann, K., Connors, T. A. (eds.), pp. 451–456. New York, London: Plenum Press 1975

    Google Scholar 

  56. Bayssas, M., Gouveie, J., De Vassal, F., Misset, J. L., Machover, D., Hayat, M., Schwarzenberg, L., Ribaud, P., Mathé, G.: Phase II clinical trial with vindesine for remission induction in leukemias and haematosarcomas. Absence of cross resistance with vincristine. Med. Oncology, Abstracts of the 45th Annual Meeting of the Medical Oncology Society, p. 3. Berlin, Heidelberg, New York: Springer 1978

    Google Scholar 

  57. Murphy, S., Hersh, E.: Immunotherapy of leukemia and lymphoma. In: Leukemia and lymphoma. Freireich, E. J., Hersh, E. M., Miescher, P. A., Jaffé, E. R. (eds.), pp. 136–158. New York, San Francisco, London: Grune & Stratton 1978

    Google Scholar 

  58. Harris, J. E., Sinkovics, J. G.: The immunology of malignant disease, pp. 449–451. Saint Louis: Mosby 1978

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Oncology, Ráth, GY. u. 7/9, 1525, Budapest PF. 21. XII, Hungary

    S. Eckhardt

Authors
  1. S. Eckhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Universitätsklinik, Joseph-Stelzmann-Straße 9, D-5000, Köln 41, Germany

    Rudolf Gross  & Klaus-Peter Hellriegel  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Eckhardt, S. (1979). Advances in the Therapy of Non-Hodgkin’s Lymphoma. In: Gross, R., Hellriegel, KP. (eds) Strategies in Clinical Hematology. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 69. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81371-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81371-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81373-3

  • Online ISBN: 978-3-642-81371-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation